Clinical Trial Update: Study of DITPA in Patients With Congestive Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of DITPA in patients with congestive heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• DITPA (3,5-diiodothyroacetic acid)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Heart Failure, Congestive | Phase 2 | Status: TERMINATED